Related Experiment Video
Updated: Mar 30, 2026
08:57
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
27.9K
Remyelination in multiple sclerosis: realizing a long-standing challenge
1a Department of Immunology , The Weizmann Institute of Science , Rehovot , Israel.
Expert Review of Neurotherapeutics
|November 13, 2015
Summary
Multiple sclerosis (MS) involves autoimmune attacks on central nervous system myelin. New therapies aim to combine immunomodulation with neuroprotection to promote myelin repair and improve outcomes.
Area of Science:
- Neuroimmunology
- Neurobiology
- Demyelinating diseases
Background:
- Multiple sclerosis (MS) is characterized by autoimmune-mediated demyelination and axonal damage in the central nervous system (CNS).
- Current therapeutic strategies face challenges in promoting remyelination beyond spontaneous levels.
- Understanding MS pathology is crucial for developing effective treatments.
Discussion:
- Immunomodulatory therapies show potential for neuroprotection and supporting repair processes.
- Novel therapeutic strategies include inhibitory molecules, monoclonal antibodies, and cell therapies.
- These approaches target oligodendrocyte populations and myelin synthesis.
Key Insights:
- Combining immunomodulatory and neuroprotective treatments is essential for MS therapy.
- Advances in biotechnology are yielding promising new therapeutic candidates.
- Several promising agents are progressing towards clinical trials.
Outlook:
- Further research into MS pathology and repair mechanisms is ongoing.
- Biotechnological advancements are accelerating the development of novel MS treatments.
- Clinical trials will evaluate the efficacy of new therapeutic strategies targeting remyelination.
Related Concept Videos
01:25Nervous Tissue: Myelin
10.2K
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
10.2K
01:15Neurogenesis and Regeneration of Nervous Tissue
2.0K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
2.0K